Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ball Corporation Common Stock (NY:BALL)

54.33 +0.56 (+1.04%)
Official Closing Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ball Corporation Common Stock

< Previous 1 2 3 4 5 Next >
NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82%
  Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday. 
Via Benzinga
Here's the Best Space Stock to Buy If You Want Passive Income
Lockheed Martin is far and away the best stock for investors who like space -- and love dividend checks. 
Via The Motley Fool
This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For Nike
UBS cut Lyft, Inc. (NASDAQ: LYFT) price target from $50 to $16. Lyft shares fell 3.7% to $13.47 in pre-market trading. 
Via Benzinga
What 11 Analyst Ratings Have To Say About Ball
Over the past 3 months, 11 analysts have published their opinion on Ball (NYSE:BALL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
KB Home, Darden Restaurants And Other Big Losers From Thursday
U.S. stocks closed lower with the Dow Jones dropping more than 100 points on Thursday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
What 8 Analyst Ratings Have To Say About Ball
Ball (NYSE:BALL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Ball Corp Hit With Downgrades, Price Target Cuts Post Q2 Results
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
Upgrades 
Via Benzinga
Why Jim Cramer Says This Financial Stock Is 'Terrific'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Charles Schwab Corporation (NYSE: SCHW) is "terrific." 
Via Benzinga
What 4 Analyst Ratings Have To Say About Ball
Ball (NYSE:BALL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Wood Mackenzie, Ball Launch New Analytics Tool For Energy Markets
Via Benzinga
Ball Aerospace Picks Rocket Lab To Power NASA's GLIDE Spacecraft
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
  
Via Benzinga
Ball Partners With Manna Capital - Read Why
Via Benzinga
Ball Corp Inks Power Purchase Agreement For New Wind Energy
Via Benzinga
Albemarle To $440? Here Are 5 Other Price Target Changes For Monday
Oppenheimer boosted Albemarle Corporation (NYSE: ALB) price target from $368 to $440. However, Oppenheimer analyst Colin Rusch maintained an Outperform rating on the stock. Albemarle shares rose 1.5%... 
Via Benzinga
U.S. Stock Futures Higher After Friday's Jobs Report
Pre-open movers 
Via Benzinga
Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday
  AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 49 companies reached new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022
Upgrades 
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
Upgrades 
Via Benzinga
It’s a Market of Stocks Not a Stock Market
Stocks are as individual as people. What really matters, in the long run, is how well the business is operated, which will always be reflected in the fundamentals. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
Via Benzinga
Stocks Pacing for Sizable Daily Wins, Steep Weekly Losses
Stocks are extending this morning's rally at midday, giving investors hope that Wall Street could finally be bouncing back from this week's selloff. 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.